Page last updated: 2024-08-23

flupirtine and Aging

flupirtine has been researched along with Aging in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bian, WJ; Chen, C; Damonte, VM; de Lecea, L; Kauer, JA; Kebschull, JM; Li, SB; Mourrain, P; Pattni, R; Purmann, C; Scherrer, G; Urban, AE; Wang, GX; Yamaguchi, H	1
de Mey, C; Deliyska, B; Gatchev, E; Terhaag, B	1
Böhm, M; Meesters, E; Meinhardt, A; Müller, WE; Pergande, G; Perovic, S	1

Trials

1 trial(s) available for flupirtine and Aging

Article	Year
Effects of advanced age and renal dysfunction on the single- and repeated-dose pharmacokinetics of modified-release flupirtine. International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:3 Topics: Administration, Oral; Adult; Age Factors; Aged; Aging; Aminopyridines; Analgesics; Area Under Curve; Biomarkers; Creatinine; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Severity of Illness Index; Young Adult	2015

Article

Year

Effects of advanced age and renal dysfunction on the single- and repeated-dose pharmacokinetics of modified-release flupirtine.

International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:3

Topics: Administration, Oral; Adult; Age Factors; Aged; Aging; Aminopyridines; Analgesics; Area Under Curve; Biomarkers; Creatinine; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Severity of Illness Index; Young Adult

2015

Other Studies

2 other study(ies) available for flupirtine and Aging

Article	Year
Hyperexcitable arousal circuits drive sleep instability during aging. Science (New York, N.Y.), 2022, 02-25, Volume: 375, Issue:6583 Topics: Aging; Aminopyridines; Animals; CRISPR-Cas Systems; Electroencephalography; Electromyography; Female; Hypothalamic Area, Lateral; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Narcolepsy; Nerve Tissue Proteins; Neural Pathways; Neurons; Optogenetics; Orexins; Patch-Clamp Techniques; RNA-Seq; Sleep; Sleep Deprivation; Sleep Quality; Wakefulness	2022
Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases. Mechanisms of ageing and development, 1998, Mar-16, Volume: 101, Issue:1-2 Topics: Aging; Alzheimer Disease; Amino Acid Sequence; Aminopyridines; Amyloid beta-Peptides; Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Glutamates; Molecular Sequence Data; Neurons; Neuroprotective Agents; Peptide Fragments; Prion Diseases; Prions; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Time Factors	1998

Article

Year

Hyperexcitable arousal circuits drive sleep instability during aging.

Science (New York, N.Y.), 2022, 02-25, Volume: 375, Issue:6583

Topics: Aging; Aminopyridines; Animals; CRISPR-Cas Systems; Electroencephalography; Electromyography; Female; Hypothalamic Area, Lateral; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Male; Mice; Narcolepsy; Nerve Tissue Proteins; Neural Pathways; Neurons; Optogenetics; Orexins; Patch-Clamp Techniques; RNA-Seq; Sleep; Sleep Deprivation; Sleep Quality; Wakefulness

2022

Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases.

Mechanisms of ageing and development, 1998, Mar-16, Volume: 101, Issue:1-2

Topics: Aging; Alzheimer Disease; Amino Acid Sequence; Aminopyridines; Amyloid beta-Peptides; Animals; Apoptosis; Calcium; Cell Survival; Cells, Cultured; Glutamates; Molecular Sequence Data; Neurons; Neuroprotective Agents; Peptide Fragments; Prion Diseases; Prions; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Time Factors

1998